Tham khảo tài liệu 'guidelines on - urinary incontinence', y tế - sức khoẻ, y dược phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả | Guidelines on Urinary Incontinence A. Schroder P. Abrams co-chairman K-E. Andersson W. Artibani . Chapple . Drake C. Hampel A. Neisius A. Tubaro . Thuroff chairman European Association of Urology European Association of Urology 2010 TABLE OF CONTENTS PAGE 1. INTRODUCTION 4 References 5 2. EPIDEMIOLOGY 5 Introduction 5 Risk factors in women 5 Risk factors in pelvic organ prolapse POP 5 Risk factors in men 5 Overactive bladder OAB 6 Disease progression 6 Longitudinal studies 6 Genetic epidemiology 6 Twin studies 6 Worldwide estimates of current and future lower urinary tract symptoms LUTS including urinary incontinence UI and OAB in individuals 20 yrs 6 Conclusions 6 References 6 3. PHARMACOTHERAPY 7 Introduction 7 Drugs used in the treatment of OAB detrusor overactivity DO 7 Drugs used in the treatment of stress urinary incontinence SIU 8 Drugs used for the treatment of overflow incontinence 9 Hormonal treatment of UI 9 Oestrogen 9 Other steroid hormones receptor ligands 10 Desmopressin 10 References 10 4. INCONTINENCE IN MEN 11 Initial assessment 11 Initial treatment 12 General management 12 Post-radical prostatectomy RP incontinence 12 Conclusions 12 Specialised management 13 Assessment 13 Interventions 13 Sphincter incompetence 13 Detrusor overactivity DO 14 Poor bladder emptying 14 Bladder outlet obstruction BOO 14 Surgical treatment 14 Incontinence after surgery for benign prostatic obstruction BPO or prostate cancer CaP 15 Incontinence after surgery for BPO 15 Incontinence after surgery for CaP 15 Definitions of post-RP continence 15 Incontinence risk factors 15 Interventional treatment for post-RP incontinence 15 Age 16 Post-RP incontinence with bladder neck stricture 16 Incontinence after external beam .
